• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2026
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • PRODUCT LIBRARY

Surgeons and device reps – one rep’s comments

August 27, 2016 By SPINEMarketGroup

In a recent article (Cafepharma.com), it was discussed the findings of a recent study that examined the relationship between surgeons and device reps. The study, which was published in Plos one, found that reps were often an integral part of the surgical team. It also raised concerns about misaligned incentives and the possibility that reps’ relationships with surgeons could adversely affect both patient care and healthcare costs.

We interviewed a veteran medical device rep to get his opinion on the article and the rep’s role in the OR. The rep we spoke with has been in the industry for 15 years. There are some possible differences between our subject’s experience and the experience of those in the study.

While orthopedic surgeons were interviewed as part of the study, it is somewhat implied that the procedures were scheduled procedures. Our subject is a trauma implant rep, and so is involved in primarily unplanned or emergency procedures.Read Interview Cafepharma.com

Related Posts:

  • The Unsung Guardians of the OR
  • 5 reasons why taking device sales reps out of the OR…
  • The "Poverty Spirit"​ Device Rep

Filed Under: NEWS Tagged With: 2016, NEWS

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
GLOBAL biomedica
NORMED newLOGO-min
GENESYS SPINE
SPINEGUARD2025
Dymicron 2
GSMEDICAL2025
spinewaygroup
RUTHLESS SPINE
RUDISHAUER
NGMEDICAL
LfC
ispine
CENTINEL SPINE
TSUNAMI MEDICAL
syntropiq logo
A-SPINE
L&Kmodelo log

POPULAR POST LAST 90 DAYS

  • Globus Medical: Stronger in Spine, but Could DePuy…
  • BROCHURES
  • Is DePuy Back in the Spine Fight? Why DePuy Really…
  • DePuy Synthes for Sale: Who Could Actually Buy the…
  • Highridge Medical CEO Departure: Spine’s…
  • Boston Scientific Puts $1.5 Billion on MiRus: Why…
  • Globus Medical: Strong Q1, Weak Stock Reaction — Is…
  • (2025 Update): Market, Leading FDA-Approved Devices,…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • Modular Pedicle Screws: When Adaptability Becomes…
  • Strong Surgery, Soft Quarter: ATEC and the Cost of…
  • COMPANIES
  • Autonomous Pedicle Screw Placement: Is Spine…
  • (UPDATED 2026) More Than 100 Options, No Single…
  • The Giant Next Door: Is Mindray Spine’s Next…
  • Cervical Fusion Implant Denials: Why Spine Societies…
  • DePuy Synthes Acquires Expanding Innovations™
  • Hospital Access Is Gone. What Comes Next for Spine…
  • VB Spine Announces VB Spine Solutions, a…
  • Top 60+ Minimally Invasive Sacroiliac Joint Fusion…
  • Sublaminar Bands in Spine Surgery: Why This Small…
  • What Is Medtronic’s PILAR™ Technique?
  • Johnson & Johnson Explores Potential $20B Sale…
  • Percutaneous MIS Spine Systems: Why Adoption Still…
  • Globus Medical Reports First Quarter 2026 Results
  • Who Is PAULA, and Why Should Every Deformity Surgeon…
  • PRODUCT LIBRARY
  • L&K Spine Performs First U.S. Deformity Case…
  • Orthopedics Is Moving Into Pain. Zimmer and Globus…
  • VB Spine Signs Master Agreement with Apolo Medica
  • LAST 5 VIDEOS PUBLISHED

    1. Mighty Oak: Acorn 3D™
    2. Syntropiq: Lyra
    3. ATEC Spine: SafeOp®
    4. REACH Medical: Expandable PLIF/TLIF Cage
    5. Expanding Innovations: X-PAC®TLIF 

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal
    • PRODUCT LIBRARY

    Copyright © 2026 · SPINEMarketGroup